{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:26Z","timestamp":1785403586053,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113454","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T23:47:05Z","timestamp":1618444025000},"page":"113454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4163-5710","authenticated-orcid":false,"given":"Eswar K.","family":"Aratikatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Kalamuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpeshkumar C.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2872-5420","authenticated-orcid":false,"given":"Gaurav","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividhya","family":"Sundararaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-1979","authenticated-orcid":false,"given":"Asif","family":"Mohmmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-522X","authenticated-orcid":false,"given":"Asish K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113454_bib1","unstructured":"Who, http:\/\/www.who.int\/malaria\/en\/."},{"key":"10.1016\/j.ejmech.2021.113454_bib2","unstructured":"World Malaria Report 2018, http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/275867\/9789241565653-eng.pdf?ua=1."},{"key":"10.1016\/j.ejmech.2021.113454_bib3","first-page":"241","article-title":"Spread of chloroquine resistance in Plasmodium falciparum, Parasitol","volume":"3","author":"Payne","year":"1987","journal-title":"Today"},{"key":"10.1016\/j.ejmech.2021.113454_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pt.2015.11.010","article-title":"Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control","volume":"32","author":"Ranson","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113454_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113454_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ddr.20344","article-title":"Artemisinin antimalarials: preserving the \u201cmagic bullet","volume":"71","author":"Maude","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2021.113454_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1368-7646(98)80208-2","article-title":"Preventing antimalarial drug resistance through combinations","volume":"1","author":"White","year":"1998","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2021.113454_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113454_bib9","series-title":"Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy: Status Report","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113454_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113454_bib11","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113454_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","article-title":"Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study","volume":"12","author":"Amaratunga","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113454_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057689","article-title":"Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar","volume":"8","author":"Kyaw","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113454_bib14","first-page":"355","article-title":"In\u00a0vivo susceptibility of Plasmodium falciparum to artesunate in binh phuoc province, Vietnam, malar","volume":"11","author":"Hien","year":"2012","journal-title":"J"},{"key":"10.1016\/j.ejmech.2021.113454_bib15","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113454_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113454_bib17","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.bbagen.2014.02.009","article-title":"Malarial hemozoin: from target to tool","volume":"1840","author":"Coronado","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113454_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113454_bib19","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1073\/pnas.1218412110","article-title":"Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum","volume":"110","author":"Chugh","year":"2013","journal-title":"Proc. Natl. Acad. Sci. ."},{"key":"10.1016\/j.ejmech.2021.113454_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113454_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/b204748a","article-title":"Hybrid systems through natural product leads: an approach towards new molecular entities","volume":"31","author":"Mehta","year":"2002","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2021.113454_bib22","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1002\/anie.200200553","article-title":"Natural product hybrids as new leads for drug discovery","volume":"42","author":"Tietze","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113454_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/tcr.201000030","article-title":"Lessons from total synthesis of hybrid natural products","volume":"10","author":"Suzuki","year":"2010","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejmech.2021.113454_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138955710791608280","article-title":"Recent progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry","volume":"10","author":"Tsogoeva","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib25","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1039\/C5OB00169B","article-title":"Design and synthesis of analogues of natural products","volume":"13","author":"Maier","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmech.2018.03.057","article-title":"Success stories of natural product-based hybrid molecules for multi-factorial diseases","volume":"151","author":"Choudhary","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib27","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A\u00a0novel artemisinin\u2013quinine hybrid with potent antimalarial activity","volume":"17","author":"Walsh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113454_bib28","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1002\/anie.201907224","article-title":"Artemisinin\u2013(iso) quinoline hybrids by C-H activation and click chemistry: combating multidrug-resistant malaria","volume":"58","author":"\u00c7apc\u0131","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113454_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derived di\/tri-mers and dendrimers, investigation of their activity against P.\u00a0falciparum and cytomegalovirus, and insights into their mechanisms of action","volume":"24","author":"Fr\u00f6hlich","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2021.113454_bib30","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.3390\/molecules22122268","article-title":"Quinoline-based hybrid compounds with antimalarial activity","volume":"22","author":"Nqoro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113454_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/C4MD00091A","article-title":"Synthesis and evaluation of artesunate\u2013indoloquinoline hybrids as antimalarial drug candidates","volume":"5","author":"Wang","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113454_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1475-2875-12-71","article-title":"Potent in\u00a0vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids","volume":"12","author":"Lombard","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113454_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1, 2, 4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib34","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.2174\/138161209789058183","article-title":"Hybrid drugs for malaria","volume":"15","author":"Walsh","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.113454_bib35","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","article-title":"Synthesis of novel hybrids of quinazoline and artemisinin with high activities against Plasmodium falciparum, human cytomegalovirus, and leukemia cells","volume":"2","author":"Fr\u00f6hlich","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113454_bib36","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.bmc.2015.04.017","article-title":"From hybrid compounds to targeted drug delivery in antimalarial therapy","volume":"23","author":"Oliveira","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib37","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy","volume":"55","author":"Capela","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113454_bib38","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmcl.2009.04.100","article-title":"Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition","volume":"19","author":"Capela","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113454_bib39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/092986711795328328","article-title":"Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria","volume":"18","author":"Teixeira","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib40","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1073\/pnas.0307720101","article-title":"Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc. Natl. Acad. Sci. ."},{"key":"10.1016\/j.ejmech.2021.113454_bib41","first-page":"1659","article-title":"Cysteine proteases of malaria parasites: targets for chemotherapy, Curr","volume":"8","author":"Rosenthal","year":"2002","journal-title":"Pharm. Des"},{"key":"10.1016\/j.ejmech.2021.113454_bib42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ijpara.2004.10.003","article-title":"Cysteine proteases of malaria parasites","volume":"34","author":"Rosenthal","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113454_bib43","doi-asserted-by":"crossref","first-page":"35236","DOI":"10.1074\/jbc.M404235200","article-title":"Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport","volume":"279","author":"Singh","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib44","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/febs.14130","article-title":"Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation","volume":"284","author":"Deu","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2021.113454_bib45","series-title":"Cysteine Proteases of Pathogenic Organisms","first-page":"30","article-title":"Falcipains and other cysteine proteases of malaria parasites","author":"Rosenthal","year":"2011"},{"key":"10.1016\/j.ejmech.2021.113454_bib46","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1172\/JCI113766","article-title":"A\u00a0malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum","volume":"82","author":"Rosenthal","year":"1988","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113454_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/345195","article-title":"Structure-function of falcipains: malarial cysteine proteases","volume":"2012","author":"Pandey","year":"2012","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113454_bib48","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/jm0505765","article-title":"Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory","volume":"49","author":"Desai","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.20163","article-title":"Falcipain-2 inhibitors","volume":"30","author":"Ettari","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113454_bib51","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/molecules18032864","article-title":"Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups","volume":"18","author":"Liu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113454_bib52","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1039\/C5OB00537J","article-title":"Synergism between genome sequencing, tandem mass spectrometry and bio-inspired synthesis reveals insights into nocardioazine B biogenesis","volume":"13","author":"Alqahtani","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib53","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1021\/ja010812a","article-title":"Optimal N-caps for N-terminal helical templates: effects of changes in H-bonding efficiency and charge","volume":"123","author":"Maison","year":"2001","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113454_bib54","first-page":"7129","article-title":"Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors, Bioorg","volume":"19","author":"Bhattacharya","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib55","doi-asserted-by":"crossref","first-page":"29025","DOI":"10.1021\/acsomega.0c03470","article-title":"Enantioselective synthesis of \u03b3-phenyl-\u03b3-amino vinyl phosphonates and sulfones and their application to the synthesis of novel highly potent antimalarials","volume":"5","author":"Aratikatla","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113454_bib56","series-title":"Novel Antimalarial Compounds, Process for Preparation and Their Use for Drug Resistant Malaria","author":"Bhattacharya","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113454_bib57","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.bmc.2015.02.062","article-title":"Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents","volume":"23","author":"Chakka","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib58","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.1021\/acs.jmedchem.7b00089","article-title":"Exploring heme and hemoglobin binding regions of Plasmodium heme detoxification protein for new antimalarial discovery","volume":"60","author":"Gupta","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib59","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/jm9607919","article-title":"Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-Substituted phenyl)-4 (R or S)-[10 (\u03b1 or \u03b2)-dihydroartemisininoxy] butyric acids1-6","volume":"40","author":"Lin","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.47.1.154-160.2003","article-title":"Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones","volume":"47","author":"Shenai","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113454_bib61","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1590\/0001-3765201820170830","article-title":"Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives","volume":"90","author":"Pinheiro","year":"2018","journal-title":"An. Acad. Bras. Ci\u00eanc."},{"key":"10.1016\/j.ejmech.2021.113454_bib62","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bmcl.2009.02.013","article-title":"Semi-synthetic and synthetic 1, 2, 4-trioxaquines and 1, 2, 4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates","volume":"19","author":"Ara\u00fajo","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113454_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2011.04.018","article-title":"Effects of highly active novel artemisinin\u2013chloroquinoline hybrid compounds on \u03b2-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum","volume":"82","author":"Feng","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113454_bib64","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","article-title":"Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion","volume":"108","author":"Klonis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. ."},{"key":"10.1016\/j.ejmech.2021.113454_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/bj3550333","article-title":"Mechanism of malarial haem detoxification inhibition by chloroquine","volume":"355","author":"Pandey","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113454_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1074-5521(02)00117-5","article-title":"Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization","volume":"9","author":"Kannan","year":"2002","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113454_bib67","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect"},{"key":"10.1016\/j.ejmech.2021.113454_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(14)70777-7","article-title":"Artemisinin resistance in Plasmodium falciparum","volume":"14","author":"Amaratunga","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113454_bib69","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum","volume":"275","author":"Shenai","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113454_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2004.02.177","article-title":"Exploring the role of putative active site amino acids and pro-region motif of recombinant falcipain-2: a principal hemoglobinase of Plasmodium falciparum","volume":"317","author":"Kumar","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113454_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000053","article-title":"HDP\u2014a novel heme detoxification protein from the malaria parasite","volume":"4","author":"Jani","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2021.113454_bib72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113454_bib73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","author":"Lambros","year":"1979","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ejmech.2021.113454_bib74","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:48Z","timestamp":1759328748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":74,"alternative-id":["S0223523421003032"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113454","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113454"}}